Preventing fungal contamination in pharmaceuticals
European Pharmaceutical Review
MARCH 11, 2024
Additionally, this can be caused by “poor handling, repackaging, and nonadherence to good manufacturing practices [GMP] during dispensing and packaging have resulted in the microbiological contamination of non-sterile pharmaceutical products.” According to the authors, these were linked to 55 fatal cases of fungal meningitis.
Let's personalize your content